AAM's Karin Hessler Provides an Inside Look at the GRx+Biosims 2019 Legal Track | Association for Accessible Medicines
New Blog - Jonathan Kimball gives more detail re: AAM's blueprint & proposed policy framework

AAM's Karin Hessler Provides an Inside Look at the GRx+Biosims 2019 Legal Track

Karin Hessler, Assistant General Counsel at the Association for Accessible Medicines, urges attendees to add their voice to the discussion at the one essential generic and biosimilar conference of the year: GRx+Biosims 2019, November 4—6 in Bethesda, MD.

The conference legal track:

  • explores drug pricing in the States;
  • tracks the changing landscape of patents;
  • analyses the challenges facing biosimilars; and
  • takes a deep dive into U.S. trade policy.

For legal professionals in the generic and biosimilars industry, this is a perfect opportunity for CEUs and CLE to receive accreditations through our interactive breakout sessions.

This is one meeting you cannot afford to miss. Learn more at https://www.grxbiosims.org/.

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.